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The Effect of Diethanolamine on Hepatic and Renal Phospholipid Metabolism in the 
Rat. BARBEE, S. J., AND HARTUNG, R. (1979). Toxicol. Appl. Pharmacol. 47,421430. DEA 
inhibited the in vitro synthesis of both phosphatidyl choline and phosphatidyl ethanol- 
amine in liver tissue. In each caSe the K, was approximately 3 mu DEA. DEA inhibited 
the formation of phosphatidyl choline competitively, and produced a mixed type of in- 
hibition for the synthesis of phosphatidyl ethanolamine. Administration of a single dose 
of 250 mg/kg DEA failed to produce inhibition of synthesis, but 330 mg/kg/day caused 
significant inhibition when given repeatedly. The most notable reduction of choline and 
ethanolamine incorporation occurred in the liver. The synthesis of ethnolamine phos- 
phoglycerides declined to 27 % of the control value after 1 week of DEA administration; 
no further reduction was seen during the remainder of the 3-week dosing regimen. Choline 
incorporation fell to 82 % of the control value after 1 week, and to 47 ‘4 and 41 y0 after 2 
and 3 weeks of DEA administration, respectively. The incorporation of these endogenous 
bases in renal tissue was also decreased. Ethanolamine phosphoglyceride synthesis de- 
clined steadily throughout the dosing regimen reaching a level 41% of control. Choline 
incorporation declined to 71 y0 or control by the end of the third week. The kinetics of 
synthesis of the phospholipid derivatives of choline, ethanolamine, and DEA proved that 
the former two compounds were synthesized at a faster rate and in greater quantities. 
They were also catabolized at a slightly faster rate than the derivatives of DEA. The bio- 
logical half-life of the phospholipid derivatives of DEA is longer than that of similar 
derivatives of choline and ethanolamine. This may favor accumulation of the DEA- 
containing phospholipid during chronic exposure. 
Diethanolamine (DEA) is a common sub- 
stance used in the chemical and pharma- 
ceutical industries as an intermediate for the 
production of detergents, solubilizers, cos- 
metics, drugs, and textile finishing agents, and 
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as an absorbent for acidic gases (Sutton, 
1963). Studies have shown that several bio- 
logically exogenous alkanolamines are cap- 
able of interacting in phospholipid meta- 
bolism by competing with choline and ethano- 
Iamine (Welch and Landau, 1942; Wells and 
Remy, 1961; Chojnacki and Korzybski, 
1963 ; Morin, 1969). Artom et al. (1958) 
noted that DEA can undergo incorporation 
into a phospholipid derivative in uivo. How- 
ever, little was known regarding the effect of 
DEA on phospholipid metabolism in viva, 
and no information existed evaluating its 
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effect on phospholipid metabolsim in citro. 
This study was undertaken to determine 
whether DEA produces inhibition of the 
synthesis of phospholipids both in vitro and in 
Go in hepatic and renal tissues from the rat. 
METHODS 
Male albino rats of the Sprague-Dawley strain 
were used throughout this investigation. The animals 
were housed in pairs in stainless-steel cages. They were 
maintained in air-conditioned quarters and supplied 
with food and water ad libitum. All animals were 
allowed to acclimate for at least 3 days. Animal 
sacrifice was accomplished by decapitation. 
Diethanolamine (DEA) was purchased from the 
J. T. Baker Chemical Company. [1,2-“C]Diethanol- 
amine was obtained from ICN Tracer Lab with a 
specific activity of 0.306 mCi/nmol. Ethanolamine was 
purchased from Eastman Organic Chemical and 
[2-3H]ethan-l-ol-2-amine hydrochloride from Amer- 
sham/Searle with a specific activity of 3.80 Ci/nmol. 
Choline chloride was purchase from Merck and 
Company and [met/zyl-3]choline chloride from 
New England Nuclear Corporation with a speci- 
fic activity of 4.2 Ci/nmol. DEA was analyzed for 
purity by thin-layer chromatography in three solvent 
systems: (I) ethyl alcohol : ammonium hydroxide 
(39x), (80 : 20); (2) methyl alcohol : ammonium 
hydroxide (39x), (80 : 20); and n-butyl alcohol : 
ammonium hydroxide (39%), (70 : 30), using alu- 
minium oxide F-254 neutral type E, layer thickness 
0.20 mm, from Brinkmann Instruments, Inc. DEA 
was visualized on the thin-layer plate using iodine 
vapor. By this procedure, only one spot was observed 
on plates from the three solvent systems. The purity 
of the [‘%]DEA was checked by thin-layer chromato- 
graphy in solvent system one. Greater than 99% of 
the radioactivity was located at +0.20 R, units from 
the R, of the nonlabeled DEA. 
All labeled samples were placed in scintillation vials 
together with a scintillation cocktail consisting of 20 g 
2,5diphenyloxazole (PPO) and 0.4 g I ,4-di(2,5- 
diphenyloxazolyl)benzene (POPOP) dissolved in 
4 liters of toluene. The samples were counted using a 
Nuclear Chicago Mark II liquid scintillation counter. 
The counting efficiency was determined by the use of 
internal standards. 
The effects of DEA on in vitro phospholipid synthesis 
were determined using the livers from adult rats. 
The animals were not deprived of food before use. 
Immediately after sacrifice, the liver was quickly 
removed and approximately 5 g was placed in an 
isolation medium at 0°C. This medium consisted of 
0.25 M special enzyme grade sucrose, 1 mhr EDTA 
(acid form), IO mM KCI, and 10 mM Tris base adjusted 
to pH 6.6 at 25°C with HCI (Brabec er al., 1974). The 
pH of Tris base is temperature dependent, and the 
pH of the solution was 7.0 at 0°C. The liver was 
minced and washed once with the isolation medium. 
The sample was transferred to a glass tissue grinding 
vessel containing approximately 20 ml of isolation 
medium and homogenized by three strokes of a 
Teflon pestle fitted to an electric motor, driven at 
600 rpm. The homogenate was equally divided be- 
tween two 30-m] glass centrifuge tubes and spun at 
1OOOg for IO min in a refrigerated centrifuge at 2-4°C. 
Upon completion, the supernatant fractions from 
each tube were combined in a 30-m] glass centrifuge 
tube and placed on ice. 
Incorporation of radioactive ethanolamine or 
choline into phosphatidyl ethanolamine or phos- 
phatidyl choline was used as a measure of phos- 
pholipid synthesis. Additionally, labeled DEA was 
used to determine the in viva synthesis of its phos- 
pholipid derivative. The incubation medium was a 
modification of that used by Weiss et al. (1958) and 
Roberts and Bygrave (1973). It contained 50 mM Tris 
buffer (pH 7.5 at 3o”C), IO mM magnesium chloride, 
0.5 mM CTP, 10 mM ATP, I PM diolein, and approxi- 
mately 2 mg of IOOOg fraction protein all in a total 
volume of 0.5 ml. The diolein solution was prepared 
by placing 2 mg diolein along with 100 mg of Tween- 
20 to act as solubilizer in 100 ml of water. The con- 
centrations of ethanolamine and choline were varied 
between 25 and 200 PM with a specific activity of 
I .O pCij50 nmol. DEA concentration was varied 
between 100 and 3000,~~. To determine the kinetic 
constants for the synthesis of the phospholipid deri- 
vative of DEA, the concentration of labeled pre- 
cursor was varied from 5 to 20 mM with a specific 
activity of 0.05 &i/pmol. Incubation tubes (125 x 
10 mm with screw caps) were used for all in oh-0 
assays. Tubes were prepared by adding distilled 
water, incubation medium, labeled precursor, and in- 
hibitor (DEA) and placing them on ice. The reaction 
was started by addition of IOOOg fraction protein. 
The tubes were immediately mixed with a Vortex 
mixer and incubated in a Dubnoff metabolic shaker 
for I hr at 37°C in duplicate. The rate of the in htro 
incorporation of choline, ethanolamine, and di- 
ethanolamine into respective phospholipid derivatives 
was investigated and found to be linear for at least 
60 min. Zero-timed blanks were used to determine the 
amount of radioactivity carried over in the extraction 
process. The reaction was stopped by the addition 
of 1.5 ml of chloroform : methanol (I : 2). This ad- 
dition also served to start the phospholipid extraction. 
The phospholipid extraction is a modification of the 
method of Bligh and Dyer (1959). Following the 
chloroform : methanol, 0.5 ml of 2~ KC1 and 
1.0 ml chloroform were added and the tubes were 
thoroughly mixed with a Vortex mixer. The tubes were 
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then centrifuged at 1OOOg to achieve phase separation. 
The lower phase was transferred to a clean tube. The 
upper phase was washed once with 1.0 ml chloro- 
form, mixed, and spun at 1OOOg. The lower phase was 
removed and added to the first extraction. The pooled 
lower phases were washed with 2.0 ml of a solution 
consisting of 47 parts 0.9 % sodium chloride, 48 parts 
methanol, and 3 parts chloroform. The tubes were 
mixed, spun at lOOOg, and then the upper phase was 
aspirated. The lower phase was taken to dryness 
under a stream of nitrogen in a water bath at 40°C. 
The phospholipids were redissolved in 1.0 ml of 
chloroform/methanol (1 : 2). An aliquot of 0.2 ml 
from each tube was transferred to scintillation vials 
and 10 ml scintillation cocktail added. The samples 
were counted as previously described. 
In order to assess the extent of inhibition of the 
synthesis of the phospholipid derivatives of choline 
and ethanolamine in hepatic and renal tissue by DEA 
in uiuo, three groups of four animals each were dosed 
for 1, 2, or 3 weeks with 2 mg/ml DEA in the drinking 
water. One group of four animals served as control. 
All animals were selected to be the same age at time of 
sacrifice. At the completion of the DEA dosing 
regimen, animals were injected ip with either 5 MCi of 
choline or ethanolamine containing no added carrier. 
They were placed in 200-mm desiccators in pairs and 
sacrificed 6 hr postinjection. 
The second part of the in uivo investigation was 
designed to determine the biological half-life of the 
phospholipid derivatives of DEA and to compare the 
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and ethanolamine to those of DEA in hepatic and 
renal tissue. Sixty-four animals were used in this 
study; 32 received 10 &i of [Y]DEA at a dose of 
250 mg/kg and 5 &i of [3H]choline (no added 
carrier) ip while the other group received a similar 
amount of [V]DEA and 5 @i of [3H]ethanolamine 
(no added carrier) via the same route. Four animals 
from each group were sacrificed at 6 hr, and 1,2,4,5, 
6, 7, and 9 days postinjection. 
Immediately after sacrifice, the liver and kidneys 
.from each animal were removed and placed in 
separate glass vessels with a volume of 5 ‘A trichloro- 
acetic acid sufficient to give a protein concentration of 
approximately 10 mg/aliquot of sample taken for 
phospholipid extraction. The tissues were homo- 
genized with a Brinkmann Polytron tissue homo- 
genizer for 30 sec. An aliquot was taken for phos- 
pholipid extraction as described above. 
The protein concentration was determined by the 
method of Lowry et al. (1951). Bovine serum albumin 
was used in the preparation of protein standards. 
Data were analyzed statistically by analysis of 
variance and by linear and nonlinear regression 
analysis. Kinetic constants were determined by the 
method of Lineweaver and Burk (1934) and inhibitor 
constants were found according to the method of 
Dixon and Webb (1964). 
RESULTS 
The effect of increasing inhibitor (DEA) 
concentration on phosphatidyl choline syn- 
- 3OOOuM DEA 
- 1OOOuM DEA 
W 300uMDEA 
- 1OOuMDEA 
O-4 NO INHIBITOR 
15 10 5 5 10 15 20 
FIG. 1. Lineweaver-Burk plot of the incorporation of choline into phosphatidyl choline in the 
presence of varying concentrations of diethanolamine. 
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thesis is summarized in the Lineweaver-Burk 
plots in Fig. 1. Regression lines indicate 
competitive inhibition of the synthesis of this 
compound by DEA, which is not surprising 
in view of the structural similarity between 
choline and DEA. 
The results obtained from the investiga- 
tion of the inhibition of phosphatidyl ethanol- 
amine synthesis by DEA are not as distinct 
as those for phosphatidyl choline. These data 
indicate, as illustrated in Fig. 2, that DEA 
produces significant inhibition of synthesis, 
but the Lineweaver-Burk plots indicate that 
it is not solely a competitive type of inhibition 
as was observed for phosphatidyl choline 
synthesis. The Ki for DEA-inhibited synthesis 
of phosphatidyl choline synthesis is 2.6- 
2.9 mM while that of phosphatidyl ethanol- 
amine synthesis is also 2.6-2.9 mM. 






FIG. 2. Lineweaver-Burk plot of the incorporation of ethanolamine into phosphatidyl ethanolamine 
in the presence of varying concentrations of diethanolamine. 
100 50 50 100 150 200 
l/IDEA1 M 
FIG. 3. Lineweaver-Burk plot of the incorporation of diethanolamine into a phospholipid derivative. 
DIETHANOLAMINE AND PHOSPHOLIPID METABOLISM 425 
TABLE 1 
LACK OF INHIBITION OF THE in Vivo SYNTHE.W OF THE PHOSPHOLIPID DERIVATIVES OF 




Counts per minute/mg protein 
Hepatic tissue Renal tissue 
Control DEA treated Control DEA treated 
Choline 1031*99 1057*70 382k35 393* 17 
Ethanolamine 1918&98 2019k96 236? 6 304* 15b 
D Each value represents the mean f  SE of data from four animals. Animals were 
administered 5 &i of [3H]ethanolamine or [3H]choline ip combined with 250 mg/ 
kg DEA and sacrificed 6 hr following injection. 
hp<0.05. 
DEA could be incorporated into a phospho- 
lipid in vitro via this enzymatic pathway. 
Figure 3 is a Lineweaver-Burk plot of the 
incorporation of DEA into a phospholipid 
derivative. From the graph, the apparent 
Km and Max were calculated to be 11.6 mM 
and 21 .O nmol/mg protein/60 min, respec- 
tively. Compared to the apparent K,,, for 
phosphatidyl choline and phosphatidyl 
ethanolamine synthesis of 75.5 and 53.5 pM, 
respectively, DEA turns out to be a less 
effective substrate for this reaction. 
Table 1 summarizes an evaluation of the 
acute effects of DEA on the in aivo synthesis 
of phospholipid derivatives of choline and 
ethanolamine. The results from this experi- 
ment are at variance with those from in vitro 
experimentation. There is no evidence of in- 
hibition of the incorporation of either base 
tested. In fact, there appears to be mild 
stimulation of synthesis in all samples. 
When DEA is administered for up to 3 
weeks, the results differ from those found 
after a single dose of DEA. The incorporation 
of [3H]ethanolamine and [3H]choline into 
hepatic and renal phospholipids is inhibited. 
The data illustrating this difference are pre- 
sented in Figs. 4 and 5. The most significant 
inhibition of the incorporation of exogenous 
tritiated ethanolamine was observed in 
hepatic tissue where it dropped to 27 % of the 
control value after only 1 week of DEA 
administration. This level was essentially 
maintained through the 3 weeks of testing. 
Choline incorporation exhibited a more 
gradual decrease; a decline to 82% of the 
control value was observed after 1 week. 
After 2 and 3 weeks of DEA administration, 
the incorporation of choline into phosphatidyl 
choline declined to 47 and 41% that of 
2000 
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FIG. 4. The effect of subacute administration of 
diethanolamine on the in uivo synthesis of phos- 
pholipid derivatives of ethanolamine. Diethanolamine 
was administered orally in drinking water at 2.0 mg/ 
ml (320 mg/kg/day). Each point represents the mean 
f  SE of data from four animals. A plus sign (+) 
denotes values which are statistically significant 
(p<O.O5). 
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FIG. 5. The effect of subacute administration of 
diethanolamine on the in viuo synthesis of phos- 
pholipid derivatives of choline. Diethanolamine was 
administered orally in drinking water at 2.0 mg/ml 
(320 mg/kg/day). Each point represents the mean 
+SE of data from four animals. A plus sign (+) 
denotes values which are statistically significant 
(p < 0.05). 
control, respectively. Decreases in incorpora- 
tion of these two bases into renal tissue were 
also seen, although not to the degree ob- 
served in liver. E3H]Ethanolamine incorpora- 
tion declined throughout the dosing regimen 
to 47 % of the control value after 3 weeks of 
DEA administration. [3H]Choline incorpora- 
tion actually increased after 1 week, but by the 
end of the third week the incorporation of 
[3H]choline into phospholipid derivatives had 
fallen to 71% of the control value. 
The elimination kinetics of the labeled 
phospholipid derivative of DEA compared to 
those of choline and ethanolamine is presented 
in Figs. 6-8. One day following the admini- 
stration of [3H]choline, [3H]ethanolamine, 
and [4C]DEA, significantly greater incor- 
poration into phospholipid derivatives was 
noted for the former two compounds. Only 
2.02% of the DEA administered was incor- 
porated into phospholipid derivatives in 
liver and 0.23 % in kidney; 7.20% of the 
administered choline and 19.8 % of the 
administered ethanolamine were incorporated 
into these lipid derivatives from hepatic 
tissue; in contrast, the kidney incorporated 
0.75% of the administered choline and 
2.69 % of the administered ethanolamine. 
This finding is to be expected; choline and 
ethanolamine are natural substrates and the 
K,,, value for DEA incorporation is roughly 
150 times that of choline and ethanolamine. 
The half-life for the disappearance of the 
phospholipid derivatives of DEA, from liver 
tissue, is approximately 3.5 days, and 4.2 
days from the kidneys. The half-life for 
labeled choline is approximately 1.7 days in 
hepatic tissue and about 2.1 days in the 
kidney. The values for ethanolamine are 
approximately 1.6 days for liver and 2.3 days 
for kidney. 
DISCUSSION 
The apparent variation in the type of 
inhibition of the synthesis of phosphatidyl 
choline and phosphatidyl ethanolamine pro- 
duced by DEA raises the interesting question 
of whether separate enzymes are involved in 
part or all of the synthesis of these two com- 
pounds. From the differences observed of the 
in vitro inhibition of phosphatidyl choline 
and phosphatidyl ethanolamine synthesis by 
DEA, it would appear that either these 
enzymes are the same but that each compound 
has its own particular active site, or that 
separate enzymes are involved. There is 
evidence to suggest that separate enzymes 
exist for a portion of the pathway for the de 
novo synthesis of phosphatidyl choline and 
phosphatidyl ethanolamine (Sung and John- 
stone, 1967; Ramasarma and Wetter, 1957; 
Broad and Dawson, 1974; Sundler, 1975). 
Acute administration of DEA failed to 
inhibit the in vivo synthesis of hepatic phos- 
pholipid derivatives of choline and ethanol- 
amine. This observation is anomalous in 
view of the in vitro findings. DEA is con- 
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FIG. 6. In uivo elimination kinetics of the hepatic phospholipid derivatives of [3H]choIine and 
[14C]diethanolamine. 
verted to a phospholipid derivative in viva 
and, under such conditions, would appear to 
have access to the enzymes which synthesize 
phospholipid derivatives of choline and 
ethanolamine. 
The inhibition of [3H]choline and [3H]etha- 
nolamine incorporation in vivo occurs only 
after repeated administration of DEA. The 
primary site of phospholipid synthesis is 
located on the endoplasmic reticulum (Wil- 
gram and Kennedy, 1963 ; Schneider, 1963 ; 
McMurray and Dawson, 1969; Jungalwala 
and Dawson, 1970a,b). In 1971, Foster 
found that repeated dosing with DEA in- 
hibited hepatic microsomal drug-metabolizing 
activity. He also found that the activity of this 
system was unaffected by in vitro exposure 
to DEA, even at concentrations of 20 mM. The 
mixed function oxidase system was also un- 
affected by acute in viva administration. The 
pattern of inhibition of phospholipid syn- 
thesis by DEA, found in this study, corre- 
lates well with the results of inhibition of 
hepatic microsomal enzyme activity ob- 
tained by Foster (1971). It is likely that the 
in vivo incorporation of DEA into hepatic 
phospholipids plays a direct role in the 
inhibition of both phospholipid synthesis and 
drug metabolism. Ellingson and Lands 
(1968) and Strobe1 et al. (1970) have found 
that specific phospholipids perform specific 
functions in cellular metabolism. The in- 
sertion of a different phospholipid into a site 
requiring a phospholipid of specific struc- 
ture would alter, in all likelihood, the function 
of that particular site. Following the inter- 
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FIG. 7. In uiuo elimination kinetics of the hepatic 
phospholipid derivatives of [3H]ethanolamine. 
pretation of Ellingson and Lands (1968), the 
effect could be a reduction in the activity of 
certain enzymes located on the endoplasmic 
reticulum. 
Since DEA appears not to affect synthesis 
of these compounds after acute administra- 
tion, thus ruling out direct involvement, the 
alternative is one of indirect action. The 
synthesis of DEA to a phospholipid deriva- 
tive probably results in its incorporation into 
membrane constituents of the endoplasmic 
reticulum, and likely would change the 
activity of enzymes dependent upon these 
membranes. The observed reduction in the 
rates of phospholipid synthesis may be due 
to reduction of the activity of enzymes located 
on the endoplasmic reticulum. 
A second observation from these data 
which deserves attention is the increased 
0.04 
- %i CHOLINE 
0.03 - % ETHANOLAMINE 
- “12. RIETHANOLAMINE 
1 2 3 4 5 6 7 8 0 
TIME (DAY.9 AFTER ADMINISTRATION 
FIG. 8. In oiuo elimination kinetics of the renal phospholipid erivatives of [3H]choline, [3H]ethanol- 
amine, and [Wldiethanolamine. 
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inhibition of in viva phospholipid synthesis in 
the liver in comparison to the kidney. In this 
particular experiment, DEA was admini- 
stered via the drinking water. Compounds 
given by the oral route are absorbed from 
the gastrointestinal tract and enter the 
hepatic portal circulation which initially 
transports them to the liver before entering 
the systemic circulation. Consequently, he- 
patic tissue has the first opportunity to 
handle metabolically orally administered 
substances. It is possible, through absorp- 
tion and metabolism by the liver, that the 
concentration of DEA presented to the 
kidney was significantly less per gram of 
tissue than for hepatic tissue. 
Incorporation into phospholipid deriva- 
tives of atypical molecules with subsequent 
insertion into membrane structure could act 
in two ways to inhibit microsomal synthesis 
of necessary cellular constituents, i.e., altera- 
tion of the enzymes themselves as well as 
reduction of synthesis of essential components 
of the membrane. The phosphoglycerides 
of DEA appear to be catabolized at a slower 
rate than those of choline and ethanolamine, 
thus confirming the prediction of Artom et al. 
(1958). The reduced rate of degradation may 
promote accumulation of such atypical 
phospholipids in body tissues. 
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